A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers.
Decensi A, Robertson C, Viale G, Pigatto F, Johansson H, Kisanga ER, Veronesi P, Torrisi R, Cazzaniga M, Mora S, Sandri MT, Pelosi G, Luini A, Goldhirsch A, Lien EA, Veronesi U.
Decensi A, et al. Among authors: sandri mt.
J Natl Cancer Inst. 2003 Jun 4;95(11):779-90. doi: 10.1093/jnci/95.11.779.
J Natl Cancer Inst. 2003.
PMID: 12783932
Free article.
Clinical Trial.